AMPK Charge+® with semaglutide clinical trials

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

This study is testing a new product called AMPK Charge+®, sometimes with a drug called semaglutide. It's for adults with prediabetes or type 2 diabetes to see how it affects their blood sugar levels over 84 days. We want to know if it's safe and effective.